BioCollective
Centennial, US · Founded 2015 · Colorado LLC
The BioCollective develops microbiome research tools, including a whole-stool BioCollector Kit, a fecal sample bank, and the Bioflux computational metabolic model used to build and evaluate probiotic consortia. Its products and reference materials serve research institutions, biotherapeutics companies, and probiotic developers, and it also produces the BiotiQuest consumer probiotic brand.
Founders & leadership
BioCollective was founded in 2015 by Matha R. Carlin and Martha Carlin.
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 3 rounds · 2015–2016
▶$1MraisedSep 2017 · 6 investors · BiotechnologyRule 506(b)
- Martha R. CarlinExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- May 2016
- Incorporated
- Limited Liability Company, Colorado, 2015
- Federal exemptions
- 06b
▶$90KraisedDec 2015 · 2 investors · BiotechnologyRule 506(b)
- Matha R. CarlinExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $90K
- First sale
- Nov 2015
- Incorporated
- Limited Liability Company, Colorado, 2015
- Federal exemptions
- 06b
▶$250KraisedNov 2015 · 2 investors · BiotechnologyRule 506(b)
- Matha R. CarlinExecutive Officer, Director, Promoter
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Oct 2015
- Incorporated
- Limited Liability Company, Colorado, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $962.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $146.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does BioCollective do?
- The BioCollective develops microbiome research tools, including a whole-stool BioCollector Kit, a fecal sample bank, and the Bioflux computational metabolic model used to build and evaluate probiotic consortia. Its products and reference materials serve research institutions, biotherapeutics companies, and probiotic developers, and it also produces the BiotiQuest consumer probiotic brand.
- Who founded BioCollective?
- BioCollective was founded by Matha R. Carlin, Martha Carlin in 2015.
- How much funding has BioCollective raised?
- BioCollective has disclosed $1.4M raised across 3 rounds.
- Where is BioCollective headquartered?
- BioCollective is headquartered in Centennial, US.